Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. (Q37699221)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 January 2010
edit
Language Label Description Also known as
English
Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity.
scientific article published on 28 January 2010

    Statements

    Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity (English)
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit